Target intelligence / Profile preview

Off-target genomic loci (Perforin 1 guide RNA)

Molecular classification
Genomic DNA
01

Overview

Off-target genomic loci represent unintended DNA sequences where a CRISPR-Cas9 complex may bind and induce double-strand breaks (Fu et al., 2013, Nature Biotechnology). In the context of Perforin 1 (PRF1) gene editing, these sites are characterized by partial sequence complementarity to the PRF1-specific guide RNA (gRNA) and the presence of a 5'-NGG-3' Protospacer Adjacent Motif (PAM) (Mojica et al., 2009, Microbiology). While the intended target is the PRF1 gene, which encodes a pore-forming protein essential for the cytotoxic activity of T cells and Natural Killer cells (UniProt KB: P14222), Cas9 can tolerate several mismatches between the gRNA and the genomic DNA. This lack of absolute specificity can lead to permanent mutations at non-target sites, potentially causing genomic instability or the disruption of tumor suppressor genes (National Institutes of Health, NIH). Identifying these loci through methods like GUIDE-seq or CIRCLE-seq is a fundamental requirement for the clinical development of gene therapies targeting PRF1-related disorders, such as Familial Hemophagocytic Lymphohistiocytosis (Tsai et al., 2015, Nature Biotechnology).

Other names
CRISPR off-target sitesUnintended genomic cleavage sitesNon-specific PRF1 gRNA binding sitesPRF1 gRNA off-targets
02

Mechanism of action

Unintended DNA double-strand breaks followed by error-prone repair (NHEJ) or homology-directed repair (HDR) at sites with partial gRNA complementarity and a compatible PAM.

03

Biological functions

Genomic integrity maintenance
04

Disease associations

GenotoxicityOncogenesisGenomic instability
05

Safety considerations

Chromosomal translocationsInsertional mutagenesisUnintended gene silencingOncogenic transformationLoss of tumor suppressor function
06

Interacting drugs

CRISPR-Cas9 (PRF1-targeted)
07

Biomarkers

GUIDE-seqCIRCLE-seqDigenome-seqIn silico off-target prediction scores

Beyond the preview

Go deeper on Off-target genomic loci (Perforin 1 guide RNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Off-target genomic loci (Perforin 1 guide RNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call